Changes in Life Sciences Unit at Avalere Health
Summary
Avalere Health today announced the hiring of Nancy McGee as executive vice president to head its thriving life sciences business unit.
Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.
McGee was previously chief operating officer of the Lash Group, a consulting firm now owned by Amerisource Bergen. She also previously worked at Manatt, Phelps & Philips, LLP, and Castlight Health.
Avalere CEO Dan Mendelson said, “Nancy is a seasoned executive and is well known to our customers as a content expert in evidence, quality, patient engagement and reimbursement. We are thrilled to add her to our team.”
Tanisha Carino, a valued member of the Avalere team for 11 years who has led the unit, will depart Avalere to lead U.S. public policy at GlaxoSmithKline.
“We are deeply grateful to Tanisha for her many contributions to Avalere’s success and look forward to working with her in her new role,” Mendelson said.
Webinar | A Closer Look at Patient Support
Avalere experts will explore how potential implications of the Inflation Reduction Act (IRA)’s out-of-pocket cap, in addition to other key regulatory and policy activities shaping benefit design and patient cost-share (e.g., EHB), could impact patient commercial and foundation assistance.
</br />
June 6, 2 PM ET
Learn More
Register